Stocks · News reference
8-K filing — NEPHROS INC (NEPH)
Filed: 2026-06-15 AccNo: 0001493152-26-028539 Size: 24 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
12 Industrials Stocks Moving In Thursday's After-Market Session
Gainers Innovate (NYSE:VATE) shares moved upwards by 36.9% to $10.15 during Thursday's after-market session. The market value of their outstanding shares is at $103.1 million. As per the news, the Q2 earnings
Nephros Q2 EPS $0.11 Beats $0.00 Estimate, Sales $6.017M Beat $4.994M Estimate
Nephros (NASDAQ:NEPH) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.00 by Infinity percent. This is a 450 percent increase over earnings of $0.02 per share from the same
Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET
Nephros, Inc. (Nasdaq: NEPH), a water technology and filtration solutions company, announced that its President and CEO Robert Banks will present at Maxim Group LLC's virtual 'Health, Wellness & Longevity' conference on July 22, 2026, at 10:00 a.m. ET. The conference brings together leaders from companies innovating in beverages, food, supplements, and longevity sectors to discuss consumer preferences and emerging trends.